Investing

Sales of short-term available-for-sale investments

Over 4 years (FY 2021 to FY 2025), Sales of short-term available-for-sale investments shows an upward trend with a 150.1% CAGR.

Analysis

StatementCash Flow Statement
SectionInvesting
First reportedQ1 2018
Last reportedQ1 2026
Metric ID: adi_sales_of_short_term_investments

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$45.10M$0.00$2.50M$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$831.80M$0.00$0.00$0.00$0.00$1.27B$596.00M$0.00$1.31B
QoQ Change-100.0%-100.0%-100.0%-52.9%-100.0%
YoY Change-100.0%-100.0%-100.0%
Range$0.00$1.31B
CAGR+103.2%
Avg YoY Growth-100.0%
Median YoY Growth-100.0%

Frequently Asked Questions

What is United Therapeutics's sales of short-term available-for-sale investments?
United Therapeutics (UTHR) reported sales of short-term available-for-sale investments of $1.31B in Q1 2026.
What is the long-term trend for United Therapeutics's sales of short-term available-for-sale investments?
Over 4 years (2021 to 2025), United Therapeutics's sales of short-term available-for-sale investments has grown at a 150.1% compound annual growth rate (CAGR), from $47.60M to $1.86B.